Effect of Carbon Dioxide Enriched Ambient Air on Pharmacokinetics and Deposition In Bronchiectasis Patients Using Tobramycin Inhalation: A proof of concept study.

Trial Profile

Effect of Carbon Dioxide Enriched Ambient Air on Pharmacokinetics and Deposition In Bronchiectasis Patients Using Tobramycin Inhalation: A proof of concept study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2012

At a glance

  • Drugs Tc 99m pentetic acid; Tobramycin
  • Indications Bacterial infections; Bronchiectasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Sep 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-001541-40).
    • 20 Aug 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database record.
    • 10 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top